142 related articles for article (PubMed ID: 28866783)
1. What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.
Boyraz G; Salman MC; Gultekin M; Ozkan NT; Uckan HH; Gungorduk K; Gulseren V; Ayik H; Toptas T; Kuru O; Sozen H; Erturk A; Ozgul N; Meydanlı MM; Sanci M; Turan T; Gungor T; Simsek T; Topuz S; Yuce K
Arch Gynecol Obstet; 2017 Nov; 296(5):979-987. PubMed ID: 28866783
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
[TBL] [Abstract][Full Text] [Related]
3. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
4. Epithelial ovarian tumors of low malignant potential: the role of microinvasion.
Buttin BM; Herzog TJ; Powell MA; Rader JS; Mutch DG
Obstet Gynecol; 2002 Jan; 99(1):11-7. PubMed ID: 11777503
[TBL] [Abstract][Full Text] [Related]
5. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
6. Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.
Gokcu M; Gungorduk K; Aşıcıoğlu O; Çetinkaya N; Güngör T; Pakay G; Cüylan ZF; Toptaş T; Özyurt R; Ağaçayak E; Ozdemir A; Erol O; Turan A; Gülseren V; İcen MS; Şenol T; Güraslan H; Yücesoy B; Sahbaz A; Gungorduk O; Besimoğlu B; Pakay K; Temizkan O; Sancı M; Şimşek T; Meydanlı MM; Harma M; Yaşar L; Boran B; Uysal AD; Karateke A
J Ovarian Res; 2016 Oct; 9(1):66. PubMed ID: 27756415
[TBL] [Abstract][Full Text] [Related]
7. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
Karlsen NMS; Karlsen MA; Høgdall E; Nedergaard L; Christensen IJ; Høgdall C
Gynecol Oncol; 2016 Jul; 142(1):50-53. PubMed ID: 27168006
[TBL] [Abstract][Full Text] [Related]
8. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
9. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
10. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
11. The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor.
Ureyen I; Karalok A; Tasci T; Turkmen O; Boran N; Tulunay G; Turan T
Int J Gynecol Cancer; 2016 Jan; 26(1):66-72. PubMed ID: 26512785
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group.
Sangnier E; Ouldamer L; Bendifallah S; Huchon C; Collinet P; Bricou A; Mimoun C; Lecointre L; Graesslin O; Raimond E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101961. PubMed ID: 33127559
[TBL] [Abstract][Full Text] [Related]
14. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
[TBL] [Abstract][Full Text] [Related]
16. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
[TBL] [Abstract][Full Text] [Related]
17. Borderline ovarian tumor in women aged ≥ 65 years: impact on recurrence and survival.
Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():38-42. PubMed ID: 25463633
[TBL] [Abstract][Full Text] [Related]
18. New Pointers for Surgical Staging of Borderline Ovarian Tumors.
Bendifallah S; Nikpayam M; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
Ann Surg Oncol; 2016 Feb; 23(2):443-9. PubMed ID: 26442919
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors predicting recurrence in borderline ovarian tumors.
Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis and fertility outcomes of patients with borderline ovarian tumors after fertility-sparing surgery].
Zhang Y; Wang QN; Huang Z; Chu R; Dong TT; Zhang YZ; Yang XS; Jiang J; Cui BX; Song K; Kong B
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1999-2004. PubMed ID: 35817724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
